Travere Therapeutics
TVTX
TVTX
108 hedge funds and large institutions have $792M invested in Travere Therapeutics in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.18% less ownership
Funds ownership: 107.17% → 106.98% (-0.18%)
5% less funds holding
Funds holding: 114 → 108 (-6)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
108
Holding in Top 10
4
Calls
$8.01M
Puts
$1.69M
Top Buyers
| 1 | +$9.76M | |
| 2 | +$5.94M | |
| 3 | +$5.27M | |
| 4 |
Goldman Sachs
New York
|
+$3.55M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.34M |
Top Sellers
| 1 | -$6.73M | |
| 2 | -$6.38M | |
| 3 | -$3.9M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$3.57M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.02M |